Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Background- When radical mastectomy with en bloc resection of the axillary contents was the primary treatment for Breast Cancer(BC), the existence of discontinuous metastases or the exact knowledge of patterns of spread of axillary lymph node(ALN) metastases was not a major concern. In the current era where surgical options for BC include incomplete axillary dissections or ALN sampling, this knowledge of lymph node spread is essential for making appropriate therapeutic decisions.Axillary dissection is an essential component of breast cancer surgery, intending to control local recurrence and classify the tumor (pN) stage. Hence the present study is undertaken to study level III ALN dissection in operable cases of breast cancer. Method- A total of 55 patients underwent Modied Radical Mastectomy (MRM) with complete axillary clearance. Demographic data and perioperative details, axillary clearance, histopathological evaluation, surgical outcome and complications were noted. Result- The majority of studies, age group was from 41-50 years (45.45%). Commonest tumor size was 2-5cm (70.91%). The most common stage was III-A(43.64%). Commonest quadrant was the upper outer (30.91%). Commonest histological type was ductal (94.55%) and grade was grade II( 61.82%). Average lymph node dissected per case was 14.3. Percentage of patients with level III lymph node involvement is 50.91% and among them, most common stage –III-A (53.57%), grade- grade II(67.86%), type- ductal (96.43%), quadrant- upper outer (39.29%), tumour size- 2-5cm (64.29%). Level III “skip metastasis” was found in 1 patient (1.8%).34.5% patients had postoperative pain. Conclusion- In a low-middle-income country like India, we advocate axillary clearance up to level III in all operable cases of breast cancer with minimal or no morbidity. However, Randomised Controlled Trials or Meta-analysis should be done for further clearance.
Background- When radical mastectomy with en bloc resection of the axillary contents was the primary treatment for Breast Cancer(BC), the existence of discontinuous metastases or the exact knowledge of patterns of spread of axillary lymph node(ALN) metastases was not a major concern. In the current era where surgical options for BC include incomplete axillary dissections or ALN sampling, this knowledge of lymph node spread is essential for making appropriate therapeutic decisions.Axillary dissection is an essential component of breast cancer surgery, intending to control local recurrence and classify the tumor (pN) stage. Hence the present study is undertaken to study level III ALN dissection in operable cases of breast cancer. Method- A total of 55 patients underwent Modied Radical Mastectomy (MRM) with complete axillary clearance. Demographic data and perioperative details, axillary clearance, histopathological evaluation, surgical outcome and complications were noted. Result- The majority of studies, age group was from 41-50 years (45.45%). Commonest tumor size was 2-5cm (70.91%). The most common stage was III-A(43.64%). Commonest quadrant was the upper outer (30.91%). Commonest histological type was ductal (94.55%) and grade was grade II( 61.82%). Average lymph node dissected per case was 14.3. Percentage of patients with level III lymph node involvement is 50.91% and among them, most common stage –III-A (53.57%), grade- grade II(67.86%), type- ductal (96.43%), quadrant- upper outer (39.29%), tumour size- 2-5cm (64.29%). Level III “skip metastasis” was found in 1 patient (1.8%).34.5% patients had postoperative pain. Conclusion- In a low-middle-income country like India, we advocate axillary clearance up to level III in all operable cases of breast cancer with minimal or no morbidity. However, Randomised Controlled Trials or Meta-analysis should be done for further clearance.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.